Pharmaceuticals
Signifier Medical Technologies Collaborates With Global Sleep Experts on Its Innovative Snoozeal(R) Device Clinical Trials
LONDON, April 23, 2020 /PRNewswire/ -- Signifier Medical Technologies, an innovator in the sleep disordered breathing market, today announced that it is partnering with twenty-seven Key Opinion Leaders in Sleep to test and build awareness around its Snoozeal® product in the lead up to its commerc...
2020-04-23 19:00
1852
Luye Pharma Group Selects LifeSphere® Signal and Risk Management to Automate Drug Safety Signal Detection
MIAMI, April 23, 2020 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, today announced Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing, and...
2020-04-23 13:00
2427
New Early Breast Cancer Drug Available Now In Singapore
* NERLYNX® (neratinib) now commercially available in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy * Five-year follow up data show NERLYNX reduces risk of invasive disease recurrence by 42% in women with early-stage, HER2+/HR+ breast cancer and who co...
2020-04-23 12:33
2158
Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs
BANGALORE, India; WILMINGTON, Delaware and ADELAIDE, Australia, April 23, 2020
/PRNewswire/ -- Bugworks Research Inc
2020-04-23 11:30
3168
Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody)
SONGDO, South Korea, April 22, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Therapeutics Inc. announced the successful FDA IND approval of IMC-002 under a development and manufacturing agreement with Samsung Biologics since 2018. As a result, ImmuneOncia will begin Phase 1 ...
2020-04-23 08:00
1471
OncoQuest Announces Signing of a Definitive Agreement to Sell Drug Portfolio to Dual Industrial for U.S. $300 Million and Commitment to Fund the Oregovomab Phase 3 Clinical Trial in Frontline Ovarian Cancer
EDMONTON, Alberta, April 23, 2020 /PRNewswire/ -- OncoQuest Inc., ("OncoQuest" or the "Company") a privately held, cancer immunotherapy company today announced that it has entered into a definitive agreement to sell its clinical and preclinical immunotherapy development assets to Dual Industrial ...
2020-04-23 01:38
8239
Standigm selects CDD Vault to augment its Drug Discovery AI technology
The hosted informatics platform will facilitate the advancement of Standigm's collaborative drug discovery projects SEOUL, South Korea and SAN FRANCISCO, April 22, 2020 /PRNewswire/ -- Originally published here: https://www.collaborativedrug.com/standigm-selects-cdd-vault-augment-drug-discovery-a...
2020-04-22 08:00
1917
WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany
SHANGHAI and LEVERKUSEN, Germany, April 22, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisition deal with Bayer for a drug product manufacturing plant in Leverkusen,Ge...
2020-04-22 08:00
2251
Clarity Pharmaceuticals Announces US FDA Grants 67Cu-SARTATE™ Orphan Drug Designation for Neuroblastoma
SYDNEY, April 21, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for67Cu-SARTATE™, a therapy for the clinica...
2020-04-21 21:13
1181
Linical and Alpha Cognition Announce Strategic Partnership to Position Alpha-1062 for Approval in the United States and Japan Alzheimer's Markets
STUART, Florida, April 21, 2020 /PRNewswire/ -- Linical Company Limited (Linical) and Alpha Cognition Inc. (ACI) today announced they have signed a partnering agreement whereby Linical will provide strategic consulting services and regulatory guidance for Alpha-1062, a new chemical entity aimed t...
2020-04-21 21:00
2740
Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity
- New, €100 million facility will more than double existing production capacity - Supports large-scale commercial manufacturing of viral and gene therapy products DARMSTADT, Germany, April 21, 2020 /PRNewswire/ -- Merck, a leading science and technology company, today announced a secondCarlsbad,...
2020-04-21 20:00
2880
Harbour BioMed Announces First Patient Dosing of Phase 1b/2a Study of Anti-FcRn Batoclimab for Treating Neuromyelitis Optica Spectrum Disorder
* First anti-FcRn PoC study for the treatment of NMOSD * Anti-FcRn antibody with potential to become a portfolio-in-a-product CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, April 21, 2020 /PRNewswire/ -- Harbour BioMed (HBM) today announced first patient dosing in a Phase1b/2a st...
2020-04-21 17:00
3217
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001
SUZHOU and HANGZHOU, China, April 20, 2020 /PRNewswire/ -- Transcenta Holding Limited. ("Transcenta"), a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacturing, today announced that its subsidiary Mabspace Biosciences (Suzhou) Co., Lim...
2020-04-20 23:00
1110
Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic
SEOUL, South Korea, April 20, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130), a biotechnology company developing innovative therapeutics in immune-oncology, announced today thatthe United States (US) Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) applic...
2020-04-20 14:41
3237
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit
SHANGHAI, April 19, 2020 According to the website of the U.S. Food and Drug Administration ("FDA"), Shanghai Fosun Pharmaceutical (Group) Co., Ltd ("Fosun Pharma"; Stock Code: 600196.SH, 02196.HK)has received emergency use authorization (EUA) from FDA for its COVID-19 RT-PCR detection kit. The t...
2020-04-19 20:00
4928
GC Pharma lights up to celebrate 'World Hemophilia Day'
YONGIN, South Korea, April 17, 2020 /PRNewswire/ -- GC Pharma (formerly known
as Green Cross Corporation), a South Korean biopharmaceutical company,
participate in campaign to celebrate World Hemophilia Day.
2020-04-17 21:00
2683
Fondazione Internazionale Menarini Creates a New Covid-19 "Virtual" Library for Doctors and Nurses: It Takes Only a Click to get the Studies Chosen by Nobel Ignarro
FLORENCE, Italy, April 17, 2020 /PRNewswire/ -- Created by the Menarini International Foundation, the collection of the most distinguished and influential scientific publications on Covid-19, selected and constantly updated under the guidance of the Nobel Prize for Medicine Louis J. Ignarro, mem...
2020-04-17 03:32
3428
Kaneka Agrees to Supply Active Pharmaceutical Ingredients for Avigan® Tablet
TOKYO, April 16, 2020 /PRNewswire/ -- Kaneka Corporation (President: Minoru Tanaka) has reached an agreement with FUJIFILM Corporation (President: Kenji Sukeno) to supply drug substances for anti-influenza drug, Avigan® Tablet (generic name: favipiravir), for the novel coronavirus disease (referr...
2020-04-16 23:33
3273
Science and Technology Daily: Chinese Approach on Medical Treatment against COVID-19
BEIJING, April 16, 2020 /PRNewswire/ -- A news report by Science and Technology Daily: Is there any specific drug to fight against COVID-19? When can we get access to the specific drug? These two questions are hard to answer for now. Developing the specific drug is quite tough. It is not practic...
2020-04-16 23:05
2303
Nimble & Svar Life Science Announce Collaboration to Discover, Develop and Commercialize Diagnostic Tests based on Nimble's Novel Biomarker Discovery Engine
MADISON, Wisconsin and MALMÖ, Sweden, April 16, 2020 /PRNewswire/ -- Nimble Therapeutics and Svar Life Science today announced a collaboration to discover, develop, and commercialize diagnostic tests based on Nimble's powerful and broadly applicable biomarker discovery engine and Svar's strongin ...
2020-04-16 23:00
1687
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5902
